Drug · DIN 02428229
LAMOTRIGINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 8, 2014; first marketed October 8, 2014.
- Drug Identification Number (DIN)
- 02428229
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lamotrigine N03AX09
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LAMOTRIGINE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 17, 2014: NOC 15838Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named LAMOTRIGINE
- DIN 02343010 · Marketed
- DIN 02343029 · Marketed
- DIN 02343037 · Marketed
- DIN 02428202 · Marketed
- DIN 02428210 · Marketed